BioSpace News Archive

The sealant was developed by Grifols and combines two plasma proteins, fibrinogen and thrombin. The spray is administered with New Jersey-based Ethicon’s airless spray device.

Merck anticipates Keytruda’s approved indications to more than double over the next five years and anticipates its oncology pipeline winning more than 50 approvals over the same time period.

Biotech and pharma companies strengthen their leadership teams and committees with new appointments.

Polyphor AG announced that it will provide an overview on its Outer Membrane Protein Targeting Antibiotics programs at the American Society of Microbiology Microbe 2019 Conference taking place in San Francisco, California, from June 20 to 24, 2019.

Partnership secures access to reserved cGMP capacity and resources at Yposkesi for manufacturing to support the global development and commercialization of Axovant’s gene therapy programs

Spero Therapeutics, Inc. announced that it entered into a collaboration with the Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis, an indication that is designated as a critical concern by the World Health Organization.

Clinical stage cannabinoid company Botanix Pharmaceuticals Limited is pleased to announce new data from studies recently conducted with its antimicrobial product BTX 1801.

Florence announced assignment of U.S. Patent No. 10,319,479 by the United States Patent and Trademark Office for: “Remote Monitoring and Dynamic Document Management Systems and Methods.”

endpoint Clinical, the leading global interactive response technology company, and Cmed Technology, the technology division of a full-service CRO with its encapsia clinical data suite, announced today a new interoperability in their clinical trial software systems.

Orion Biotechnology Canada Ltd., announced new preclinical data evaluating the efficacy of OB-002 in colorectal cancer.